Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Here you’ll learn which entities edit index rules, how edits are proposed, reviewed, and finalized, and why transparent processes matter.
10,903 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
As U.S.–Iran tensions flare, energy prices surge and corporate boards adjust risk, liquidity and strategy in a newly ...
Korean chip equities are wavering after a blistering AI-driven rally, with the KOSPI retreating and memory peers weig...
New York’s decision to pause large-scale data center projects up to a year changes the playing field for cloud giants...
Fresh analyst notes Thursday spark upgrades across Alphabet, Meta, Palo Alto Networks and more, signaling growing opt...
A blockbuster June lift sent crypto prediction markets to new highs as a string of sports finals and championships dr...
August could bring more shares to the market as insiders unlock. This article breaks down what spacex's lockup starts...
Jim Cramer advised switching away from speculative tech toward industrial stalwarts, naming FedEx, Honeywell Aerospac...
A fresh look at SCHD shows that funding a cash-flow retirement with quarterly dividends still requires several millio...
Oil climbs to the $70 range as the Fed signals a tighter stance, renewing risk-off sentiment that weighs on Bitcoin. ...
Markets steadied after the Supreme Court struck down sweeping tariffs, a move largely priced in by investors. Wall St...
A major institutional purchase has put Enviri in the spotlight. This article breaks down what the $43 million buy mea...